COMPANY PROFILE
| Price and Volume | |
|---|---|
| Recent Price | 42.26 |
| 52 Week High | 42.98 |
| 52 Week Low | 27.15 |
| Avg. Daily Vol. (Mil) | 1.46 |
| Beta (3 year) | 0.66 |
| Share Related Items | |
| Mkt Cap (Mil) | 119,623.61 |
| Shares Out (Mil) | 2,830.66 |
| Float (Mil) | 0.00 |
| Dividend Information | |
| Yield % | 4.60 |
| Annual Dividend | 1.96 |
| Payout Ratio | 111.00 |
| Financial Strength | |
| Quick Ratio | 1.20 |
| Current Ratio | 1.60 |
| LT Debt/ Equity | 1.62 |
| Total Debt / Equity | 1.82 |
| Valuation Ratios | |
| Price Earnings | 25.70 |
| Price/Sales | 4.84 |
| Price/Book | 8.06 |
| Price/Cash Flow | 18.60 |
| Per Share Data | |
| Earnings | 1.65 |
| Sales | 8.74 |
| Book Value | 5.24 |
| Cash Flow | 2.28 |
| Business Summary | |
|---|---|
| A global healthcare Group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products including vaccines, over-the-counter medicines and health-related consumer products. | |
| General Information | |
| 980 Great West Road
Brentford, Middles, TW8 9GS |
|
| 0.99999999936235 | |
| www.gsk.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 99003 | |
| CEO: Andrew Witty | |
| Short Interest | |
| Current Month (Mil) | 4.43 |
| Previous Month (Mil) | 4.68 |
| Short Interest Ratio (Days) | 2.60 |
| Management Effectiveness | |
| Return on Equity | 28.40 |
| Return on Assets | 6.40 |
| Return on Investments | 10.80 |
| Profitability | |
| Gross Margin | 82.30 |
| EBIT Margin | 27.60 |
| Profit Margin | 17.00 |